The impact of cardiometabolic multimorbidity on cognitive function in older adults: a review

Huan Liu1, Junxiang Sun1, Ting Wang1

  • 1Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Insights

Cardiometabolic multimorbidity (CMM) significantly accelerates cognitive decline and dementia in older adults. This review synthesizes CMM

Area of Science:

  • Gerontology
  • Neurology
  • Cardiology

Background:

  • Cardiometabolic multimorbidity (CMM) is a prevalent chronic condition.
  • CMM is strongly linked to cognitive impairment and dementia progression.
  • Current research on cognitive function in CMM is limited, especially in older adults.

Purpose of the Study:

  • To review the impact of CMM on cognitive function in older adults.
  • To synthesize current knowledge on the correlation between CMM and cognitive impairment.
  • To explore underlying mechanisms, assessment tools, and risk factors for cognitive dysfunction in CMM.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of studies focusing on cardiometabolic diseases and cognitive function.
  • Examination of data on older adults with multiple cardiometabolic conditions.

Main Results:

  • CMM is a significant driver of cognitive dysfunction and dementia.
  • Existing studies often overlook the complex interplay of multiple cardiometabolic diseases.
  • Specific correlations, mechanisms, and risk factors require further investigation.

Conclusions:

  • CMM poses a substantial threat to cognitive health in aging populations.
  • There is a critical need for comprehensive understanding and management of CMM to prevent cognitive decline.
  • Insights gained can inform screening and management strategies for high-risk individuals.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
402
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
406
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
378
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.4K